Embecta Corporation Registered Shs When Issued Aktie
WKN DE: A3DGNE / ISIN: US29082K1051
|
09.02.2024 16:16:11
|
Embecta Sinks As Outlook Comes In Below Consensus
(RTTNews) - Shares of diabetes care company Embecta Corp. (EMBC) are falling more than 12 percent Friday morning after the company provided full-year profit outlook below the Street view.
Embecta now expects adjusted profit in the range of $1.95 - $2.15 for the full year. Analysts on average, polled by Thomson-Reuters expects the company to report earnings of $2.22 per share.
Revenue for the full year is expected in the range of $1.094 billion - $1.116 billion. This compares with the consensus estimate of $1.1 billion for the year.
EMBC is at $15.48 currently. It has traded in the range of $12.72 - $33.88 in the last 1 year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Embecta Corporation Registered Shs When Issuedmehr Nachrichten
|
08.05.25 |
Ausblick: Embecta stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) |
Analysen zu Embecta Corporation Registered Shs When Issuedmehr Analysen
Aktien in diesem Artikel
| Embecta Corporation Registered Shs When Issued | 11,50 | 0,00% |
|